# Correction: Govaerts et al. Incidence and Clinical Features of Pseudoprogression in Brain Metastases After Immune-Checkpoint Inhibitor Therapy: A Retrospective Study. Cancers 2025, 17, 2425

**Authors:** Chris W. Govaerts, Miranda C. A. Kramer, Ingeborg Bosma, Frank A. E. Kruyt, Frederike Bensch, J. Marc C. van Dijk, Mathilde Jalving, Anouk van der Hoorn

PMC · DOI: 10.3390/cancers18040572 · 2026-02-10

## Full-text entities

- **Genes:** AKR1C3 (aldo-keto reductase family 1 member C3) [NCBI Gene 8644] {aka DD3, DDX, HA1753, HAKRB, HAKRe, HSD17B5}
- **Diseases:** Brain Metastases (MESH:D001932), death (MESH:D003643), NC (OMIM:617025), injury to (MESH:D014947), tumour (MESH:D009369)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12939313/full.md

---
Source: https://tomesphere.com/paper/PMC12939313